Teladoc Health Files 8-K on Shareholder Votes

TL;DR

TDOC filed an 8-K for shareholder votes - nothing specific yet, but they're voting on stuff.

AI Summary

Teladoc Health, Inc. filed an 8-K on May 23, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or resolutions presented, but it confirms the company's adherence to reporting requirements for such events.

Why It Matters

This filing indicates that Teladoc Health held a shareholder meeting where important corporate decisions were put to a vote, a standard but necessary disclosure for public companies.

Risk Assessment

Risk Level: low — The filing is a routine procedural disclosure and does not contain any new financial or operational information that would immediately impact the company's risk profile.

Key Players & Entities

• Teladoc Health, Inc. (company) — Registrant
• May 23, 2024 (date) — Date of Report
• Delaware (jurisdiction) — State of incorporation
• 2 Manhattanville Road Suite 203 Purchase, NY 10577 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 per share TDOC The New York Stock Excha

Filing Documents

• tdoc-20240523.htm (8-K) — 48KB
• 0001477449-24-000122.txt ( ) — 172KB
• tdoc-20240523.xsd (EX-101.SCH) — 2KB
• tdoc-20240523_lab.xml (EX-101.LAB) — 22KB
• tdoc-20240523_pre.xml (EX-101.PRE) — 13KB
• tdoc-20240523_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Stockholders (the "Annual Meeting") of Teladoc Health, Inc. (the "Company") was held on May 23, 2024. The Company previously filed with the Securities and Exchange Commission a definitive proxy statement and related materials pertaining to the Annual Meeting, which describe in detail each of the four proposals submitted to stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below. Proposal 1 — Election of Directors The stockholders of the Company elected each of the following director nominees proposed by the Company's Board of Directors to serve until the 2025 Annual Meeting of Stockholders of the Company and until their respective successors have been duly elected and qualified. The voting results for each director nominee are set forth below. Name For Against Abstentions Broker Non-Votes J. Eric Evans 88,196,267 1,534,638 200,724 33,206,768 Sandra L. Fenwick 86,299,372 3,440,112 192,145 33,206,768 Catherine A. Jacobson 87,169,749 2,567,831 194,049 33,206,768 Thomas G. McKinley 85,013,791 4,740,342 177,496 33,206,768 Kenneth H. Paulus 74,899,349 14,833,526 198,754 33,206,768 David L. Shedlarz 86,291,066 3,440,248 200,315 33,206,768 Mark Douglas Smith, M.D., MBA 86,043,205 3,693,113 195,311 33,206,768 David B. Snow, Jr. 78,319,070 11,431,566 180,993 33,206,768 Proposal 2 — Advisory Vote Approving the Compensation of the Company's Named Executive Officers The stockholders of the Company approved, on an advisory basis, the compensation paid to the Company's named executive officers. The voting results are set forth below. For Against Abstentions Broker Non-Votes 86,004,216 3,679,987 247,426 33,206,768 Proposal 3 — Advisory Vote on Frequency of Future Advisory Votes Approving the Compensation of the Company's Named Executive Officers The stockholders of the Company approved, on an ad

View Full Filing

View this 8-K filing on SEC EDGAR